ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer
Featuring
perspectives from Prof Francois-Clement Bidard, Dr Erika Hamilton,
Dr Komal Jhaveri, Dr Virginia Kaklamani and Dr Hope S Rugo,
including the following topics:
Introduction (0:00)
Optimal Integration of CDK4/6 Inhibitors into
the Management of ER-Positive Metastatic Breast Cancer (mBC) — Dr
Kaklamani (7:00)
Novel Strategies to Overcome Resistance to
Endocrine Therapy — Dr Jhaveri (26:20)
Current Role of Antibody-Drug Conjugates in
the Management of ER-Positive mBC — Dr Rugo (1:00:09)
Current and Future Role of Selective Estrogen
Receptor Degraders (SERDs) in the Management of ER-Positive mBC —
Prof Bidard (1:28:59)
Novel Therapies Under Investigation for
Patients with ER-Positive mBC — Dr Hamilton (1:40:50)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.